3,5-BIS(BROMOMETHYL)BENZOIC ACID, 98%, 1g

Methyl 2-cyano-6-methylbenzoate, 95.0%, 1g

N,N-Bis[2-(p-tolylsulfonyloxy)ethyl]-p-toluenesulfonamide>98.0%(HPLC)(N)5g

Di-?-chlorobis[2-[(dimethylamino)methyl]phenyl-C,N]dipalladium(II), 97%, 1g

(S)-tert-butyl 2-(4-(3-ethylureido)phenyl)-4-(3-methylmorpholino)-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate, 98%, 250mg

5-chloro-3-(3,4-dimethoxyphenyl)-1,2,4-thiadiazole, 95.0%, 2g

2-Phenylsulfanyl-5-trifluoromethyl-benzoic acid, 95.0%, 1g

3,5-Dimethylbenzeneboronic acid, 98.0%, 25g

[(2-phenyl-1,3-oxazol-4-yl)methyl]amine hydrochloride, 95.0%, 1g

Diethylcarbamazine>98.0%(GC)5g

Colonne HPLC NUCLEODUR® C8 Gravité 5 µm, 250 mm, 4 mm, 1 Pièce(s)

(2,4-Dinitro-phenyl)-methyl-amine, 95.0%, 1g

4-phenylcyclohexanone oxime, 95.0%, 1g